MGC Pharmaceuticals' Securities Will be Cleared by Pershing

  • Dec 18, 2019 AEDT
  • Team Kalkine
Securities of MGC Pharmaceuticals Ltd (ASX: MXC) were removed from the restricted list of BNY Mellon’s Global Cannabis Security Policy. The move comes after the restriction was applied in October this year.
  • BNY Mellon and its clearing house Pershing Securities had restricted the securities.
  • The restriction resulted in non-acceptance of MXC securities along with other cannabis businesses.
  • The list also included Australian listed cannabis companies.
  • Securities of MGC Pharma were permitted for trading from 30 November 2019 after a review.
By 12:51 PM AEDT, MXC was trading at $0.032, up 3.22 per cent from the previous close.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK